Solutions for Life Science & Diagnostics

Anti-SLC22A5/OCTN2 polyclonal antibody Trial size

Ordering Guide

SKUNameSizeQtyPriceAdd to Cart
BMP076B Anti-SLC22A5/OCTN2 polyclonal antibody Trial size 10μL $99.50

Additional Information

Anti-SLC22A5/OCTN2 polyclonal antibody Trial size Specifications

Background:The members of the solute carrier family 22 (SLC22) belong to the organic cation/anion/zwitterion transporter family. SLC22A5, which is also known as OCTN2, is expressed in the muscle, heart, and kidney. It is mainly involved in the transportation of carnitine in a sodium-dependent manner. Primary systemic carnitine deficiency is caused by mutations in the SLC22A5 gene. A mouse with a spontaneous mutation in the slc22a5 gene, which is designated as juvenile visceral steatosis (JVS), develops an enlarged fatty liver, steatosis of other organs, and hypertrophic cardiomyopathy, and eventually dies at 4 to 5 weeks unless carnitine is administered. Defects in SLC22A5/OCTN2 may also lead to increased susceptibility to Crohn’s disease.
Clonality:Polyclonal
Gene ID Human:6584
Gene ID Mouse:20520
Host Species:Rabbit
Regulatory Statement:For Research Use Only. Not for use in diagnostic procedures.
Isotype:IgG
Product Type:Primary Antibody
Shipping:4
Size:10μL
Status:RUO
Storage:-20
Target:SLC22A5/OCTN2

Applications:

There are no additional documents for Anti-SLC22A5/OCTN2 polyclonal antibody Trial size at this time.

There are no references for Anti-SLC22A5/OCTN2 polyclonal antibody Trial size at this time.

 

Product Images

Anti-SLC22A5/OCTN2 polyclonal antibody Trial size